Cibc World Market Inc. Biogen Inc. Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $4.79 Million - $5.45 Million	-18,654 Reduced 64.46%	10,287 $2.86 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $3.29 Million - $4 Million	13,031 Added 81.9%	28,941 $8.01 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $156,725 - $216,110	-805 Reduced 4.82%	15,910 $4.25 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $275,871 - $328,062	1,471 Added 9.65%	16,715 $3.41 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $842,705 - $1.06 Million	4,349 Added 39.92%	15,244 $3.21 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.27 Million - $1.63 Million	5,668 Added 108.44%	10,895 $2.61 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $706,626 - $921,517	2,497 Added 91.47%	5,227 $1.48 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $473,970 - $758,919	-1,830 Reduced 40.13%	2,730 $945,000
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $1.14 Million - $1.34 Million	-4,709 Reduced 50.8%	4,560 $1.28 Million
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $1.76 Million - $2.65 Million	7,446 Added 408.45%	9,269 $2.27 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1.57 Million - $1.81 Million	-5,929 Reduced 76.48%	1,823 $517,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $773,393 - $1.02 Million	2,990 Added 62.79%	7,752 $2.07 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $414,029 - $525,201	1,540 Added 47.8%	4,762 $1.51 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $257,910 - $356,370	-1,172 Reduced 26.67%	3,222 $956,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $127,637 - $143,157	-587 Reduced 11.78%	4,394 $1.02 Million
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $1.37 Million - $1.52 Million	-6,268 Reduced 55.72%	4,981 $1.17 Million
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $55,044 - $86,095	-254 Reduced 2.21%	11,249 $2.66 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $932,975 - $1.18 Million	-3,350 Reduced 22.55%	11,503 $3.46 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $5.65 Million - $7.39 Million	-19,264 Reduced 56.46%	14,853 $5.25 Million
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $1.9 Million - $2.27 Million	7,386 Added 27.63%	34,117 $9.9 Million
Q1 2018 May 18, 2018	SELL	$260.13 - $367.91 $4.1 Million - $5.79 Million	-15,749 Reduced 37.07%	26,731 $7.32 Million
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $60,605 - $67,882	197 Added 0.47%	42,480 $13.5 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $11.9 Million - $13.9 Million	42,283	42,283 $13.2 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account